caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1578529731

Paul NeusteinMD

PRACTICEPAUL NEUSTEIN MD INCSee all providers at this practice →
UrologyPoway, CAI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
REFERRAL NETWORK

Where Paul Neustein's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 27 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
PALOMAR HEALTH1851,130
PALOMAR HEALTH137544
UNDERWOOD, JAMES3070
Unilab Corporation
Clinical Laboratory · West Hills, CA
3048
Kiran Patel
Diagnostic Radiology · Oceanside, CA
2984
LAKEWOOD PATHOLOGY ASSOCIATES, INC.2963
Anurag Goyal
Interventional Radiology · San Diego, CA
2678
Jeffrey Lozier
Ophthalmology · Poway, CA
2357
NPI 12453312302246
Tan Nguyen
Diagnostic Radiology · Dallas, TX
1942
Belinda Dure-Smith
Internal Medicine · Poway, CA
1958
JOSWIG, BILL1882
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
131
Unique beneficiaries
—
Total services
163
Distinct HCPCS
5
Medicare payment
$8K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 942 Urology providers in CA — below median (cohort median 1,637).
PRESCRIBING · PART D · 2024
Total Rx claims
513
Beneficiaries
—
Total drug cost
$53K
Distinct drugs
11
Brand share
24.2%
Top prescribed drugs
Tamsulosin Hcl163 claims
Finasteride113 claims
Mirabegron53 claims
Oxybutynin Chloride48 claims
Cephalexin30 claims
QUALITY · MIPS · 2024
Final MIPS score
85.6
Quality
64.4
Cost
72.9
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
0.45%
Group
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
No data available for this provider in 2024.